Related Experiment Video

Updated: Jun 24, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation

Naa-Adjeley Ablorh1, Florentin Nitu, Kristin Engebretsen

  • 1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55101, USA.

Clinical Toxicology (Philadelphia, Pa.)
|April 15, 2009
PubMed

Insights

High-dose insulin (HDI) does not improve heart function in beta-blocker or calcium channel blocker toxicity by altering phospholamban (PLB) phosphorylation. This study investigated the mechanism behind HDI

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Cardiogenic shock induced by beta-blockers (BB) or calcium channel blockers (CCB) presents a significant clinical challenge.
  • High-dose insulin (HDI) has shown potential in treating such conditions, but its underlying mechanism remains unclear.
  • Phospholamban (PLB) phosphorylation regulates calcium handling in the heart, influencing contractility and relaxation.

Purpose of the Study:

  • To investigate whether the beneficial effects of high-dose insulin (HDI) in beta-blocker (BB) or calcium channel blocker (CCB)-induced cardiogenic shock are mediated by phospholamban (PLB) phosphorylation.
  • To determine the role of PLB phosphorylation in the cardiac response to toxic BB and CCB infusions treated with HDI.

Main Methods:

  • Swine models were used, divided into six groups receiving various combinations of medications (saline, HDI, BB, CCB) and infusions.
  • Cardiac tissue was analyzed using quantitative immunoblots to measure levels of phosphorylated PLB (pPLB) and total PLB.
  • A beta-adrenergic agonist (isoproterenol) was used to validate the assay's ability to detect PLB phosphorylation.

Main Results:

  • No significant differences in either phosphorylated PLB (pPLB) or total PLB were observed in cardiac tissue across all experimental groups.
  • Isoproterenol infusion successfully induced enhanced PLB phosphorylation, confirming the assay's validity.
  • These findings indicate that HDI's effects are not linked to alterations in PLB phosphorylation status.

Conclusions:

  • The inotropic and lusitropic effects of high-dose insulin (HDI) in reversing BB- and CCB-induced cardiovascular toxicity are not mediated by changes in phospholamban (PLB) phosphorylation.
  • The study concludes that alterations in PLB phosphorylation or total PLB content do not explain HDI's therapeutic mechanism in these models of cardiogenic shock.
Abstract

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...